Does Rallies show 13F holders for EYE?

Yes. Rallies tracks hedge fund and 13F ownership data for EYE, including fund names, share counts, latest tracked quarter, and position changes when available.

Is EYE research on Rallies investment advice?

No. Rallies provides research, data, and educational context for EYE. It does not provide personalized investment advice.

EYE (National Vision Holdings, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

National Vision Holdings, Inc. Common Stock (EYE) is a publicly traded Consumer Cyclical sector company. As of May 20, 2026, EYE trades at $16.84 with a market cap of $1.39B and a P/E ratio of 46.39. EYE moved -0.53% today. Year to date, EYE is -35.53%; over the trailing twelve months it is -13.11%. Its 52-week range spans $9.56 to $30.02. Analyst consensus is buy with an average price target of $29.56. Rallies surfaces EYE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns EYE stock?

Hedge funds tracked by Rallies that own EYE include Glenview Capital, Centerbook Partners, Maverick Capital, Bridgewater Associates, and Mangrove Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for National Vision Holdings, Inc. Common Stock.

EYE Key Metrics

Key financial metrics for EYE
Metric	Value
Price	$16.84
Market Cap	$1.39B
P/E Ratio	46.39
EPS	$0.37
Dividend Yield	0.00%
52-Week High	$30.02
52-Week Low	$9.56
Volume	2.84M
Avg Volume	0
Revenue (TTM)	$1.99B
Net Income	$29.60M
Gross Margin	0.00%

Top Hedge Funds Holding EYE

Glenview Capital holds 1.57M shares of EYE, changed +9.56% as of Mar 31, 2026.
Centerbook Partners holds 84.84K shares of EYE, changed +0.00% as of Dec 31, 2023.
Maverick Capital holds 74.68K shares of EYE, changed +159.42% as of Sep 30, 2025.
Bridgewater Associates holds 26.52K shares of EYE, changed +72.69% as of Mar 31, 2026.
Mangrove Partners holds 19.27K shares of EYE, changed +0.00% as of Dec 31, 2025.

Latest EYE News

National Vision Target Cut to $25 After Q1 Revenue Miss, 4.5% Sales Growth — May 14, 2026
National Vision Sees Robust Q1 Optical Sales Growth and Margin Expansion — May 14, 2026
National Vision EPS Up 26.5% to $0.43, Revenue $544M — May 13, 2026
National Vision’s Q1 Profit Tops Estimates; Revenue Slightly Misses — May 13, 2026
Rise Nano Optics Gains FDA Class I Classification for SPECTRAGUARD Lens Filtering 100% UV, 90% Blue Light — Mar 23, 2026

Recent EYE Insider Trades

Wilkes Alexander sold 35.00K (~$928.90K) on Mar 11, 2026.
FAHS L READE sold 7.60K (~$224.84K) on Mar 6, 2026.
FAHS L READE sold 4.07K (~$120.38K) on Mar 6, 2026.

EYE Analyst Consensus

10 analysts cover EYE: 0 strong buy, 7 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $29.56.

Common questions about EYE

Who owns EYE stock?: Hedge funds tracked by Rallies that own EYE include Glenview Capital, Centerbook Partners, Maverick Capital, Bridgewater Associates, and Mangrove Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for National Vision Holdings, Inc. Common Stock.
Does Rallies show 13F holders for EYE?: Yes. Rallies tracks hedge fund and 13F ownership data for EYE, including fund names, share counts, latest tracked quarter, and position changes when available.
Is EYE research on Rallies investment advice?: No. Rallies provides research, data, and educational context for EYE. It does not provide personalized investment advice.